Genscript Biotech's market cap is currently $37.08B. The company's EPS TTM is HK$-0.17114229704; its P/E ratio is 0.97; Genscript Biotech is scheduled to report earnings on August 17, 2025, and the estimated EPS forecast is HK$-0.08. See an overview of income statement, balance sheet, and cash flow financials.
